Laura Carter, Ph.D, joins Character Bio as Chief Scientific Officer

Character Biosciences raises new funding round to accelerate the development of targeted therapies for diseases of aging.

Our lead investor explains their investment thesis in Character

Cantos describes why they have chosen to partner with Character through multiple rounds of financing

The CEO of Clover Health details the aligned missions for Clover & Character and our progress

Our CEO shares Character's patient-first DNA